Haleon plc (NYSE:HLN - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $10.37, but opened at $9.99. Haleon shares last traded at $10.01, with a volume of 1,276,908 shares traded.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on HLN. Berenberg Bank began coverage on shares of Haleon in a research note on Tuesday, August 6th. They set a "buy" rating for the company. The Goldman Sachs Group downgraded shares of Haleon from a "buy" rating to a "neutral" rating in a research note on Tuesday, August 6th. Morgan Stanley lifted their price target on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research note on Friday, September 20th. Finally, UBS Group upgraded Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $10.95.
Get Our Latest Stock Report on Haleon
Haleon Stock Down 3.3 %
The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The firm has a market cap of $45.80 billion, a PE ratio of 34.57, a P/E/G ratio of 3.12 and a beta of 0.26. The business's 50-day simple moving average is $10.09 and its 200 day simple moving average is $9.03.
Haleon (NYSE:HLN - Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). The business had revenue of $3.50 billion for the quarter, compared to the consensus estimate of $3.55 billion. Haleon had a net margin of 9.71% and a return on equity of 13.15%. During the same quarter in the prior year, the business posted $0.08 earnings per share. As a group, equities research analysts expect that Haleon plc will post 0.47 earnings per share for the current year.
Haleon Cuts Dividend
The business also recently disclosed a semi-annual dividend, which was paid on Thursday, September 19th. Investors of record on Friday, August 16th were paid a dividend of $0.0514 per share. This represents a dividend yield of 1.6%. The ex-dividend date was Friday, August 16th. Haleon's dividend payout ratio (DPR) is currently 33.33%.
Institutional Trading of Haleon
A number of institutional investors have recently modified their holdings of the company. AE Wealth Management LLC lifted its position in Haleon by 6.1% during the second quarter. AE Wealth Management LLC now owns 19,199 shares of the company's stock valued at $159,000 after acquiring an additional 1,098 shares during the last quarter. Cardinal Capital Management raised its holdings in shares of Haleon by 2.5% during the second quarter. Cardinal Capital Management now owns 46,231 shares of the company's stock worth $382,000 after purchasing an additional 1,140 shares during the last quarter. Endowment Wealth Management Inc. lifted its holdings in shares of Haleon by 9.9% in the 2nd quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company's stock valued at $106,000 after buying an additional 1,161 shares during the period. Portside Wealth Group LLC lifted its holdings in Haleon by 2.7% in the second quarter. Portside Wealth Group LLC now owns 44,985 shares of the company's stock valued at $372,000 after acquiring an additional 1,182 shares during the period. Finally, Lester Murray Antman dba SimplyRich boosted its holdings in Haleon by 2.9% during the second quarter. Lester Murray Antman dba SimplyRich now owns 45,519 shares of the company's stock worth $375,000 after buying an additional 1,301 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors.
About Haleon
(
Get Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
